Thankfully, in recent decades, the United States has seen remarkable progress in the fight against breast cancer. Around the same time C.J. was diagnosed, the mapping of the human genome ushered in a new era of research aimed at saving lives and stopping cancer. In fact, the death rate for breast cancer alone has declined by 36 percent since the 1980s.
“I’m certain I would not be alive if it wasn’t for modern medicine,” C.J. says. “It’s important that every patient get the chance to survive longer.”
The number of cancer survivors like C.J. has been steadily rising in recent decades, and every treatment discovered extends that trend into the long-term. More than 800 medicines and vaccines are in development in the United States, signaling incredible progress in developing new treatments and cures.
Today, C.J. continues to defy expectations, thanks to modern medicine and innovative breakthroughs. She is a prime example of the impact of the lifesaving work being done by scientists and researchers across the country.
“I think it’s very important that every patient be given the chance to survive longer.”
Sign up to stay informed and learn how to protect innovation when it matters most.
©2024 Pharmaceutical Research and Manufacturers of America, 670 Maine Avenue, SW, Suite 1000, Washington, DC 20024
Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how we and third parties use pixel tags, and how that use affects you, click here.
